Riskpilot← Back to searchSign inGet full accessMedcare i Limhamn AB
ABActiveOrg 5568923410Elbegatan 5 2trWholesale of pharmaceutical and medical goods · NACE 4646Est. 20120 employees
Revenue 2024
SEK 1,4M
+46% vs 2023
EBITDA margin
16.9%
+892% vs 2023
Equity ratio
54.4%
Financial strength
Net profit 2024
SEK 152K
+15100% vs 2023
| Revenue | SEK 1,4M | +46% |
| EBITDA | SEK 238K | +892% |
| Net profit | SEK 152K | +15100% |
| Total assets | SEK 1M | +13% |
| Equity | SEK 565K | +25% |
| Employees | 0 | — |
Legal name
Medcare i Limhamn AB
Org number
5568923410
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
4 maj 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att Bolaget skall bedriva partihandel med medicinsk utrustning och apoteksvaror. Konsultverksamhet avseende företagsorganisation.
Address
Elbegatan 5 2tr
Email
michael.leibig@medcare.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 297 | 504 | 1 296 | 962 | 1 405 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 55 | 7 | 714 | 24 | 238 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 55 | 7 | 714 | 24 | 238 |
| Net financials | −31 | −3 | −1 | — | −7 |
| Profit before tax | 8 | 5 | 532 | 9 | 193 |
| Tax | −10 | −2 | −112 | −8 | −41 |
| Net profit | −2 | 3 | 420 | 1 | 152 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 466 | 377 | 858 | 922 | 1 038 |
| Equity | 176 | 179 | 450 | 451 | 565 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 228 | 136 | 165 | 215 | 181 |
| Total debt | 228 | 136 | 165 | 215 | 181 |
EBITDA margin
16.9%
This company
15.8%
Market median
+7% vs market
20202024
Equity ratio
54.4%
This company
38.2%
Market median
+42% vs market
20202024
Return on equity
26.9%
This company
18.4%
Market median
+46% vs market
20202024
Net profit margin
10.8%
This company
8.1%
Market median
+33% vs market
20202024
Asset turnover
1.35×
This company
1.12×
Market median
+21% vs market
20202024
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AK | Audit | 2022 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medcare i Limhamn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Kenneth Larsson | Audit | 0 companies |
| Ivana Maria Cyrne Leibig | Deputy Board Member | 0 companies |
| Hans Gerhard Leibig | Deputy Board Member | 0 companies |
| Michael Leibig | Board of Directors | 0 companies |